Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Mar;19(2):157-64.
doi: 10.1007/s00384-003-0532-x. Epub 2003 Sep 12.

Long-term Effect of 5-fluorouracil Enhanced by Intermittent Administration of Polysaccharide K After Curative Resection of Colon Cancer. A Randomized Controlled Trial for 7-year Follow-Up

Affiliations
Clinical Trial

Long-term Effect of 5-fluorouracil Enhanced by Intermittent Administration of Polysaccharide K After Curative Resection of Colon Cancer. A Randomized Controlled Trial for 7-year Follow-Up

Katsuki Ito et al. Int J Colorectal Dis. .

Abstract

Background and aims: The efficacy of a biological response modifier polysaccharide K in adjuvant immunochemotherapy was evaluated in primary colon cancer patients with macroscopic Dukes' C after curative resection.

Patients and methods: Employing the minimization method using three factors (lymph node metastases, preoperative serum CEA level, and institution), 446 patients were allocated into groups P and C. Group P received immunochemotherapy, oral PSK (3 g per day) followed by oral 5-FU (200 mg/body per day), while group C received only intermittent chemotherapy, oral 5-FU (200 mg per day) followed by 4-week rest. Both groups received ten courses.

Results: Survival for cancer death was significantly higher in group P than in group C, but there was no difference in 7-year disease-free survival or overall survival had.

Conclusion: Repeated alternating administration with PSK followed by 5-FU can improve survival for cancer death.

Similar articles

See all similar articles

Cited by 8 articles

See all "Cited by" articles

References

    1. Cancer. 1986 Aug 1;58(3):603-10 - PubMed
    1. Immunol Lett. 1992 Feb 15;31(3):241-5 - PubMed
    1. Anticancer Res. 1992 May-Jun;12 (3):645-8 - PubMed
    1. Anticancer Res. 1995 Mar-Apr;15(2):255-8 - PubMed
    1. Jpn J Clin Oncol. 1995 Jun;25(3):91-103 - PubMed

MeSH terms

Feedback